AtonRa Partners Trims Position in Kymera Therapeutics, Inc. (NASDAQ:KYMR)

AtonRa Partners decreased its stake in shares of Kymera Therapeutics, Inc. (NASDAQ:KYMR – Free Report) by 7.7% in the second quarter, HoldingsChannel reports. The institutional investor owned 21,947 shares of the company’s stock after selling 1,832 shares during the period. AtonRa Partners’ holdings in Kymera Therapeutics were worth $505,000 at the end of the most […]

Related Keywords

Wellington ,New Zealand General ,New Zealand ,Stifel Nicolaus ,Morgan Stanley ,Wellington Management Group ,Kymera Therapeutics Inc ,Artal Group ,Credit Suisse Group ,Avoro Capital Advisors ,Pricet Rowe Associates Inc ,Nasdaq ,Kymera Therapeutics Company Profile ,Atonra Partners ,Kymera Therapeutics ,Free Report ,Capital Advisors ,Street Corp ,Management Group ,Suisse Group ,Get Free Report ,Visit Holdingschannel ,Kymera Therapeutics Daily ,Nasdaq Kymr ,Kymr ,Medical ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,